Jaubert, Julien
Atiana, Laura
Larrieu, Sophie
De Vos, Philippe
Somon-Payet, Claudine
Porcherat, Sylvaine
Mboussou, Yoan
Naze, Florence
Picot, Sandrine
Boukerrou, Malik
Robillard, Pierre-Yves
Gérardin, Patrick
Funding for this research was provided by:
GIRCI SOHO, APIDOM grant 2012 (None)
Article History
Received: 18 March 2019
Accepted: 12 March 2020
First Online: 3 April 2020
Ethics approval and consent to participate
: The E-Q-RUN study was conducted in accordance with the Declaration of Helsinki and the French legislation for biomedical research (Nu ID RCBAFSSAPS: 2013-A00397–38/ NCT02898402). It was approved both by the <i>Comité de Protection des Personnes</i> (CPP) of Bordeaux 2 University (2013/36), the <i>Comité Consultatif sur le Traitement de l’Information en matière de Recherche dans le domaine de la Santé</i> (CCTIRS) of Paris (2013/13.275 bis). These allowed the use of clinical and serum data after oral consent was obtained from all parturient women aged ≥18 years, as proposed for standard care in French university hospitals (Article L1121 du Code de la Santé Publique, modifié par ordonnance n°2010–177 du 23/02/2010). Written consent was not warranted given the procedure of blood sampling was included in those required for per partum monitoring under standard care.The oral consent was informed by the means of an information sheet which was explained face to face by the investigators. The data collection (2013/913371) was curated under the rules of the <i>Comission Nationale de l’Informatique et des Libertés</i> (CNIL).
: Not applicable.
: The authors declare that they have no competing interests.